Literature DB >> 3018757

Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

Y Shavit, A Depaulis, F C Martin, G W Terman, R N Pechnick, C J Zane, R P Gale, J C Liebeskind.   

Abstract

We previously reported that a single systemic injection of a high dose of morphine (greater than or equal to 20 mg/kg) transiently suppresses splenic natural killer cell cytotoxicity in rats. The present study examined the possibility that the immune-suppressive effect of morphine is mediated by opiate receptors in the brain. Supporting this hypothesis, we found that morphine (20 or 40 micrograms) injected into the lateral ventricle suppressed natural killer cell activity to the same degree as a systemic dose higher by three orders of magnitude. This effect was blocked by an opiate antagonist, naltrexone. Natural killer cell activity was unaffected by systemic administration of N-methyl morphine, a morphine analogue that does not cross the blood-brain barrier. These data implicate opiate receptors in the brain in morphine-induced suppression of natural killer cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018757      PMCID: PMC386663          DOI: 10.1073/pnas.83.18.7114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance.

Authors:  Y Shavit; G W Terman; J W Lewis; C J Zane; R P Gale; J C Liebeskind
Journal:  Brain Res       Date:  1986-05-07       Impact factor: 3.252

2.  Stress and cancer.

Authors:  L S Sklar; H Anisman
Journal:  Psychol Bull       Date:  1981-05       Impact factor: 17.737

Review 3.  Psychoneuroendocrinological effects on the immune response.

Authors:  G F Solomon; A A Amkraut
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

4.  Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice.

Authors:  P S Hochman; G Cudkowicz
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

5.  A comparison of the pharmacologic effects of morphine and N-methyl morphine.

Authors:  R S Foster; D J Jenden; P Lomax
Journal:  J Pharmacol Exp Ther       Date:  1967-07       Impact factor: 4.030

6.  Beta-endorphin-induced increases in plasma epinephrine, norepinephrine and dopamine in rats: inhibition of adrenomedullary response by intracerebral somatostatin.

Authors:  G R Van Loon; N M Appel; D Ho
Journal:  Brain Res       Date:  1981-05-11       Impact factor: 3.252

7.  Regulation of natural killer activity in vivo. III. Effect of hypophysectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population.

Authors:  Q B Saxena; R K Saxena; W H Adler
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

8.  Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.

Authors:  M Benczur; G G Petrányl; G Pálffy; M Varga; M Tálas; B Kotsy; I Földes; S R Hollán
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

9.  Effect of intraventricular beta-endorphin and morphine on hypothalamic-pituitary-adrenal activity and the release of pituitary beta-endorphin.

Authors:  J L Haracz; A S Bloom; R I Wang; L F Tseng
Journal:  Neuroendocrinology       Date:  1981-09       Impact factor: 4.914

Review 10.  Natural killer cells: their roles in defenses against disease.

Authors:  R B Herberman; J R Ortaldo
Journal:  Science       Date:  1981-10-02       Impact factor: 47.728

View more
  16 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide.

Authors:  V Srinivasan; D Wielbo; J Simpkins; J Karlix; K Sloan; I Tebbett
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

3.  Opioids and the immune system: what is their mechanism of action?

Authors:  Toby K Eisenstein
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  [The effect of peridural analgesia on long-term survival after surgery in patients with colorectal cancer : A systematic meta-analysis].

Authors:  J P N Holler; J Ahlbrandt; M Gruß; A Hecker; M A Weigand; W Padberg; R Röhrig
Journal:  Chirurg       Date:  2015-07       Impact factor: 0.955

5.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 6.  Opioids, gliosis and central immunomodulation.

Authors:  Salim Kadhim; John McDonald; David G Lambert
Journal:  J Anesth       Date:  2018-07-27       Impact factor: 2.078

7.  Opiates and the development of post-injury complications: a review.

Authors:  Martin G Schwacha
Journal:  Int J Clin Exp Med       Date:  2008-01-20

8.  Immunomodulatory activity of mu- and kappa-selective opioid agonists.

Authors:  D D Taub; T K Eisenstein; E B Geller; M W Adler; T J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.

Authors:  Lee W Hutson; Jennifer L Szczytkowski; Timothy B Saurer; Christina Lebonville; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2014-01-24       Impact factor: 7.217

10.  Morphine-induced enhancement in the granulocyte response to thioglycollate administration in the rat.

Authors:  Karamarie Fecho; Donald T Lysle
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.